Myocardial metabolism in toxin-induced heart failure and therapeutic implications

被引:12
作者
Hantson, Philippe [1 ,2 ]
Beauloye, Christophe [3 ]
机构
[1] Clin St Luc, Dept Intens Care, B-1200 Brussels, Belgium
[2] Clin St Luc, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Dept Cardiovasc Intens Care, Clin St Luc, B-1200 Brussels, Belgium
关键词
Myocardial metabolism; stunned myocardium; takotsubo cardiomyopathy; drug poisoning; insulin; LEFT-VENTRICULAR DYSFUNCTION; TAKO-TSUBO; STRESS CARDIOMYOPATHY; VERAPAMIL TOXICITY; INSULIN; BUPIVACAINE; INFUSION; DOGS; PET;
D O I
10.3109/15563650.2012.658472
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background. Under normal conditions, myocardial metabolism is 60-80% reliant on the oxidation of fatty acids. This can be modified by conditions such as ischemia or poisoning with specific drugs, with the myocardium becoming more dependent on carbohydrate metabolism for energy. Acute poisoning with cardiotoxic drugs may be complicated by heart failure that is at present usually treated by inotropic drugs and vasopressors. However, changes in metabolic processes in poisoning may offer an opportunity for novel therapies. Current evidence. The scientific evidence obtained from ischemia-reperfusion models and the preservation of myocardial metabolism when myocardial blood flow is restored after a brief coronary occlusion (a theory known as "myocardial stunning") support this concept. Generalized or localized myocardial stunning may develop in patients who do not present with acute myocardial ischemia secondary to coronary artery disease, a condition referred to as takotsubo cardiomyopathy. This is characterized by the preservation of myocardial blood flow, associated with a depressed myocardial contractility, lasting from hours to weeks. Therapeutic implications. Several factors have been associated with takotsubo cardiomyopathy:- excessive sympathetic stimulation, either from exogenous or endogenous origin; drug poisoning or drug withdrawal. The metabolism of both glucose and fatty acids appears to be reduced in the hypocontractile areas. One of the hypotheses is that the catecholamine-mediated myocardial insulin resistance may be responsible for reduced glucose uptake. Among the drugs taken in overdose, calcium channel blockers and beta-blockers have been shown to influence myocardial metabolism, with a shift from fatty acids to glucose utilization. This is the rationale for the administration of insulin in order to stimulate glucose myocardial uptake. In addition, insulin at high doses seems also to have inotropic effects, which are independent from its effects on myocardial substrate handling. Conclusion. Better understanding of the relationship between the receptor interactions of myocardial toxins and their effects on myocardial metabolism is likely to result in the development of new targeted therapies aimed specifically at optimising metabolic processes in poisoning.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 50 条
[41]   Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes [J].
House, Andrew A. ;
Haapio, Mikko ;
Lassus, Johan ;
Bellomo, Rinaldo ;
Ronco, Claudio .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (04) :759-773
[42]   Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes [J].
Cui Daxin ;
Feng Xingrong ;
Lei Siman ;
Zhang Hongmei ;
Hu Wanxin ;
Yang Shanshan ;
Yu Xiaoqian ;
Su Zhiguang .
中华医学杂志英文版, 2024, 137 (07)
[43]   Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes [J].
Cui, Daxin ;
Feng, Xingrong ;
Lei, Siman ;
Zhang, Hongmei ;
Hu, Wanxin ;
Yang, Shanshan ;
Yu, Xiaoqian ;
Su, Zhiguang .
CHINESE MEDICAL JOURNAL, 2024, 137 (07) :791-805
[44]   Pathophysiological basis of myocardial innervation imaging in heart failure [J].
Bauckneht M. ;
Sambuceti G. ;
Pomposelli E. ;
Fiz F. ;
Marini C. .
Clinical and Translational Imaging, 2015, 3 (5) :347-355
[45]   Transient Myocardial Thickening in Cats Associated with Heart Failure [J].
Matos, J. Novo ;
Pereira, N. ;
Glaus, T. ;
Wilkie, L. ;
Borgeat, K. ;
Loureiro, J. ;
Silva, J. ;
Law, V. ;
Kranjc, A. ;
Connolly, D. J. ;
Fuentes, V. Luis .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2018, 32 (01) :48-56
[46]   TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure [J].
Kleinbongard, Petra ;
Heusch, Gerd ;
Schulz, Rainer .
PHARMACOLOGY & THERAPEUTICS, 2010, 127 (03) :295-314
[47]   Myocardial Viability Testing in the Management of Ischemic Heart Failure [J].
Babes, Elena Emilia ;
Tit, Delia Mirela ;
Bungau, Alexa Florina ;
Bustea, Cristiana ;
Rus, Marius ;
Bungau, Simona Gabriela ;
Babes, Victor Vlad .
LIFE-BASEL, 2022, 12 (11)
[48]   Heart failure after myocardial infarction: incidence and predictors [J].
Jenca, Dominik ;
Melenovsky, Vojtech ;
Stehlik, Josef ;
Stanek, Vladimir ;
Kettner, Jiri ;
Kautzner, Josef ;
Adamkova, Vera ;
Wohlfahrt, Peter .
ESC HEART FAILURE, 2021, 8 (01) :222-237
[49]   High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates [J].
Wawrzyniak, Andrew J. ;
Dilsizian, Vasken ;
Krantz, David S. ;
Harris, Kristie M. ;
Smith, Mark F. ;
Shankovich, Anthony ;
Whittaker, Kerry S. ;
Rodriguez, Gabriel A. ;
Gottdiener, John ;
Li, Shuying ;
Kop, Willem ;
Gottlieb, Stephen S. .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (10) :1527-1533
[50]   The Atrioventricular Coupling in Heart Failure: Pathophysiological and Therapeutic Aspects [J].
Di Terlizzi, Vito ;
Barone, Roberta ;
Di Nunno, Nicola ;
Alcidi, Gianmarco ;
Brunetti, Natale Daniele ;
Iacoviello, Massimo .
REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (05)